LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

LLY

737.79

+2.36%↑

JNJ

154.98

+1.05%↑

ABBV

185.51

+0.1%↑

NVO

71.33

+2.71%↑

UNH

300.93

+0.94%↑

Search

Minerva Neurosciences Inc

Chiusa

1.52 3.4

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.49

Massimo

1.52

Metriche Chiave

By Trading Economics

P/E

Media del settore

1.653

53.54

Dipendenti

8

Dividendi

By Dow Jones

Utili prossimi

5 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

656K

9M

Apertura precedente

-1.88

Chiusura precedente

1.52

Minerva Neurosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

30 mag 2025, 23:51 UTC

Acquisizioni, Fusioni, Takeovers

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30 mag 2025, 21:30 UTC

Notizie principali

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30 mag 2025, 21:15 UTC

Notizie principali

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30 mag 2025, 20:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

30 mag 2025, 20:44 UTC

Acquisizioni, Fusioni, Takeovers

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30 mag 2025, 20:24 UTC

Notizie principali

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30 mag 2025, 20:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

30 mag 2025, 19:44 UTC

Discorsi di Mercato

Gold Breaks 4-Month Winning Streak -- Market Talk

30 mag 2025, 19:38 UTC

Discorsi di Mercato

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30 mag 2025, 19:29 UTC

Utili
Acquisizioni, Fusioni, Takeovers

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30 mag 2025, 19:14 UTC

Discorsi di Mercato

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30 mag 2025, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30 mag 2025, 18:51 UTC

Discorsi di Mercato

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30 mag 2025, 18:37 UTC

Discorsi di Mercato
Utili

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30 mag 2025, 18:04 UTC

Notizie principali

S&P 500 Falls After More Trump-China Friction -- WSJ

30 mag 2025, 17:47 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

30 mag 2025, 17:47 UTC

Discorsi di Mercato

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30 mag 2025, 17:40 UTC

Acquisizioni, Fusioni, Takeovers

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30 mag 2025, 17:38 UTC

Discorsi di Mercato

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30 mag 2025, 17:31 UTC

Discorsi di Mercato

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30 mag 2025, 17:14 UTC

Notizie principali

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30 mag 2025, 16:31 UTC

Utili

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30 mag 2025, 16:20 UTC

Discorsi di Mercato

Tech, Media & Telecom Roundup: Market Talk

30 mag 2025, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Health Care Roundup: Market Talk

30 mag 2025, 16:16 UTC

Notizie principali

S&P 500 Falls After Trump Hits Out at China -- WSJ

30 mag 2025, 16:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

30 mag 2025, 16:14 UTC

Notizie principali

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

30 mag 2025, 16:12 UTC

Discorsi di Mercato

Base Metal Prices Slide on Stronger Dollar But Copper Shortage Fears Remain -- Market Talk

30 mag 2025, 16:02 UTC

Discorsi di Mercato

Latest Twists in U.S. Tariff Saga Being Digested by Commodity Markets -- Market Talk

30 mag 2025, 15:31 UTC

Notizie principali

Judge Considers Curbs for Google in AI Arms Race -- Update

Confronto tra pari

Modifica del prezzo

Minerva Neurosciences Inc Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

$

Chi Siamo Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.